Differential expression of cyclin D1 in breast papillary carcinomas and benign papillomas: An immunohistochemical study

Archives of Pathology and Laboratory Medicine

Volumn 123, Issue 2, 1999, Pages 152-156

  Saddik, M ^a,d   Lai, R ^b   Medeiros, L J ^b   McCourty, A ^c   Brynes, R K ^c  

^a UNIVERSITY OF SASKATCHEWAN   (Canada)

^b CITY OF HOPE NATIONAL MEDICAL CENTER   (United States)

^c UNIVERSITY OF SOUTHERN CALIFORNIA   (United States)

^d UNIVERSITY OF SASKATCHEWAN   (Canada)

Author keywords

[No Author keywords available]

Indexed keywords

CYCLIN D1; KI 67 ANTIGEN;

ANTIGEN EXPRESSION; BREAST BIOPSY; BREAST CARCINOMA; CELL CYCLE S PHASE; CELL POPULATION; CELL PROLIFERATION; CONFERENCE PAPER; EPITHELIUM CELL; FLUORESCENCE IN SITU HYBRIDIZATION; HUMAN; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; IMMUNOREACTIVITY; PAPILLARY CARCINOMA; PAPILLOMA; RECEPTOR UPREGULATION;

ADULT; AGED; AGED, 80 AND OVER; BREAST NEOPLASMS; CARCINOMA, PAPILLARY; CYCLIN D1; FEMALE; HUMANS; IMMUNOHISTOCHEMISTRY; IN SITU HYBRIDIZATION, FLUORESCENCE; MIDDLE AGED; PAPILLOMA;

EID: 0032958162     PISSN: 00039985     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Conference Paper

References (30)

1. Carter D. Intraductal papillary tumors of the breast: a study of 76 cases. Cancer. 1979;39:1689-1692.
2. Foote FW Jr, Stewart FW. A histologic classification of carcinoma of the breast. Surgery. 1946;19:74-99.
3. Rosen PP. Rosen's Breast Pathology. Philadelphia, Pa: Lippincott-Raven; 1997:341-354.
4. Kraus FT, Neubecker RD. The differential diagnosis of papillary tumors of the breast. Cancer. 1962;15:444-455.
5. Hendrick JW. Intraductal papilloma of the breast. Surg Gynecol Obstet. 1957;105:215-223.
6. Buhl-Jorgesen SE, Fischermann K, Johansen H, Peterson B. Cancer risk in intraductal papilloma and papillomatosis. Surg Gynecol Obstet. 1968;127:307-313.
7. Kilgore AR, Fleming R, Ramos N. The incidence of cancer with nipple discharge and the risk of cancer in the presence of papillary disease of the breast. Surg Gynecol Obstet. 1953;96:649-660.
8. Rosen PP, Oberman HA. Invasive carcinoma. In: Tumors of the Mammary Gland. Washington, DC: Armed Forces Institute of Pathology; 1992:157-257. Atlas of Tumor Pathology.
9. Rosen PP, Oberman HA. Invasive carcinoma. In: Tumors of the Mammary Gland. Washington, DC: Armed Forces Institute of Pathology; 1992:157-257. Atlas of Tumor Pathology.
10. Hunter T, Pines J. Cyclins and cancer, II: cyclin D and cdk inhibitors come of age. Cell. 1994;79:573-582.
11. Helin K, Harlow E. The retinoblastoma protein as a transcriptional repressor. Trends Cell Biol. 1993;3:43-46.
12. Weinberg RA. The retinoblastoma protein and cell cycle control. Cell. 1995;81:323-330.
13. Slansky JE, Farnham PJ. Introduction to the E2F family: protein structure and gene regulation. In: Farnham PJ, ed. Transcriptional control of cell growth: the E2F gene family. Berlin, Germany: Springer; 1996:1-30. Current Topics in Microbiology and Immunology.
14. Bates S, Peters G. Cyclin D1 as a cellular proto-oncogene. Cancer Biol. 1995;6:73-82.
15. Gillet C, Smith P, Gregory W, et al. Cyclin D1 and prognosis in human breast cancer. Int J Cancer. 1996;69:92-99.
16. Weikel W, Beck T, Mitze M, Knapstein PG. Immunohistochemical evaluation of growth fractions in human breast cancers using monoclonal antibody Ki-67. Breast Cancer Res Treat. 1991;18:149-154.
17. Gerdes J, Lemke H, Baisch H, Wacker HH, Schwab U, Stein H. Cell cycle analysis of a cell proliferation associated human nuclear antigen defined by the monoclonal antibody Ki-67. J Immunol. 1984;133:1710-1715.
18. McGurrin JF, Doria MI Js, Dawson PJ, Karrison T, Stein H, Franklin WA. Assessment of tumor cell kinetics by immunohistochemistry in carcinoma of breast. Cancer. 1987;59:1744-1750.
19. Michalides R, Hageman P, van Tinteren H, et al. A clinicopathological study on overexpression of cyclin D1 and of p53 in a series of 248 patients with operable breast cancer. Br J Cancer. 1996;73:728-734.
20. Brynes RK, McCourty A, Tamayo R, Jenkins K, Battifora H. Demonstration of cyclin D1 (bcl-1) in mantle cell lymphoma: enhanced staining using head and ultrasound epitope retrieval. Appl Immunohistochem. 1997;5:45-48.
21. Brynes RK, McCourty A, Ho JP, Traweek ST, Synder DS, Slovak ML. Detection of the Philadelphia chromosome in paraffin-embedded tissue by fluorescence in situ hybridization. Mod Pathol. 1994;7:565-569.
22. Barnes DM. Cyclin D1 in mammary carcinoma. J Pathol. 1997;181:267-269.
23. Frierson HF Jr, Gaffey MJ, Zukerberg LR, Arnold A, Williams ME. Immunohistochemical detection and gene amplification of cyclin D1 in mammary infiltrating ductal carcinoma. Mod Pathol. 1996;9:725-730.
24. Zhang SY, Caamano J, Cooper F, Guo X, Klein-Szanto AJP. Immunohistochemistry of cyclin D1 in human breast cancer. Am J Clin Pathol. 1994;102:695-698.
25. van Diest PJ, Michalides RJAM, Jannink I, et al. Cyclin D1 expression in invasive breast cancer: correlation and prognostic value. Am J Pathol. 1997;150: 705-711.
26. Fantl V, Smith R, Brookes S, Dickson C, Peters G. Chromosome 11q13 abnormalities in human breast cancer. Cancer Surv. 1993;18:77-94.
27. Peters G, Fand V, Smith R, Brookes S, Dickson C. Chromosome 11q13 markers and D-type cyclins in breast cancer. Breast Cancer Res Treat. 1995;33: 125-135.
28. Bodrug SE, Warner BJ, Bath ML, Lindermna GJ, Harris AW, Adams JM. Cyclin D1 transgene impedes lymphocyte maturation and collaborates in lymphomagenesis with the myc gene. EMBO J. 1994;13:2124-2130.
29. Wang TC, Cardiff RD, Zukerburg L, Lees E, Arnold A, Schmidt EV. Mammary hyperplasia and carcinoma in MMTV-cyclin D1 transgenic mice. Nature. 1994;369:669-671.
30. Wakasugi E, Kobayashi T, Tamaki Y, et al. Analysis of phosphorylation of pRN and its regulatory proteins in breast cancer. J Clin Pathol. 1997;50:407-412.